SCHEMBL7572092

SCHEMBL7572092

N#Cc1ccc(CO)cc1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.56
MAOA P21397 3/20 0.45
MAOB P27338 3/20 0.45
ESR2 Q92731 1/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
GALR3 O60755 1/20 0.44
GAA P10253 1/20 0.44
WNT3A P56704 1/20 0.40
BACE1 P56817 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MCL1 Q07820 1/20 0.40
FFAR1 O14842 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7137268 0.92 CYP19A1 (0.50) CYP19A1MAOAMAOBESR2ALDH1A1
SCHEMBL7570638 0.92 CYP19A1 (0.49) CYP19A1MAOAMAOBESR2ALDH1A1
SCHEMBL3910779 0.86 CYP19A1 (0.56) CYP19A1MAOAMAOBESR2ALDH1A1
SCHEMBL7576136 0.84 AR (0.47) CYP19A1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7569910 0.84 CYP19A1 (0.43) CYP19A1ESR2FFAR1AKR1B1CYP11B1
SCHEMBL8155256 0.84 CYP19A1 (0.55) CYP19A1MAOAMAOBESR2ALDH1A1
SCHEMBL7575872 0.83 CYP19A1 (0.46) CYP19A1MAOAMAOBESR2BACE1
SCHEMBL29038973 0.81 CYP19A1 (0.52) CYP19A1MAOAMAOBALDH1A1CYP1A2
SCHEMBL7576242 0.80 AR (0.44) ESR2TSHR
SCHEMBL7569971 0.79 CYP19A1 (0.40) CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed
US-6077853-A Inhibitors of farnesyl-protein transferase MERCK & CO., INC. (US) 2000-06-20 US disclosed
EP-0951285-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 1999-10-27 EP disclosed
US-5939439-A Inhibitors of farnesyl-protein transferase MERCK & CO., INC. (US) 1999-08-17 US disclosed
WO-1998029119-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1998-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 CYP19A1 589/4885MAOA 2136/4885MAOB 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.